Integral Health Asset Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-350,000
Closed -$12.5M 78
2023
Q2
$12.5M Buy
+350,000
New +$12.6M 1.54% 22
2022
Q1
Sell
-80,000
Closed -$4.41M 80
2021
Q4
$4.41M Buy
+80,000
New +$4.16M 1.22% 31

Other funds holding GSK

Integral Health Asset Management's GSK Position: Q3 2023 in Review

Integral Health Asset Management sold out of GSK (GSK) in Q3 2023, closing a stake of 350,000 shares — an estimated $12.5M sold.

Integral Health Asset Management first reported a position in GSK in Q4 2021 and held it in 2 quarters. The position peaked at $12.5M in Q2 2023. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • Integral Health Asset Management reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
  • Integral Health Asset Management sold 350,000 GSK shares in Q3 2023, an estimated $12.5M.
  • Integral Health Asset Management first reported a position in GSK in Q4 2021 and held it in 2 quarters.
  • Integral Health Asset Management's GSK position peaked at $12.5M in Q2 2023.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Integral Health Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.